APO Research
Talk to an analyst

APO RESEARCH · REPORT

Long-Read Sequencing Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Long-Read Sequencing Services Market Outlook and Growth Opportunities 2026

5 June 2026212 pages

Choose your research edition.

Industry ResearchLong-Read Sequencing Services Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-Read Sequencing Services Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Long-Read Sequencing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-Read Sequencing Services Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-Read Sequencing Services Market Analysis and Forecast 2026-2032236 pages · $4,950 USD

Market perspective

The global Long-Read Sequencing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Long-Read Sequencing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Long-Read Sequencing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-Read Sequencing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Long-Read Sequencing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Long-Read Sequencing Services market include Oxford Nanopore, Agilent Technologies, Thermo Fisher Scientific, QIAGEN, PacBio, Illumina, Takara Bio, 10X Genomics and Danaher, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Long-Read Sequencing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Long-Read Sequencing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Long-Read Sequencing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Long-Read Sequencing Services market.

Long-Read Sequencing Services Segment by Company

Oxford Nanopore

Agilent Technologies

Thermo Fisher Scientific

QIAGEN

PacBio

Illumina

Takara Bio

10X Genomics

Danaher

Azenta US

Revvity

New England Biolabs

BaseClear

Element Biosciences

CD Genomics

Sage Sciences

EdenRoc Sciences

Genewiz

BGI Group

Novogene

Grandomics

Wuhan Beina Technology

Long-Read Sequencing Services Segment by Type

Nanopore Sequencing

Single-molecule Real-time Sequencing

Synthetic Long-read Sequencing

Long-Read Sequencing Services Segment by Application

Research Institutes

Hospitals

Pharmaceutical

Others

Long-Read Sequencing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Long-Read Sequencing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Long-Read Sequencing Services key companies, revenue, market share, and recent developments.

3. To split the Long-Read Sequencing Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Long-Read Sequencing Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Long-Read Sequencing Services significant trends, drivers, influence factors in global and regions.

6. To analyze Long-Read Sequencing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Read Sequencing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-Read Sequencing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Read Sequencing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Long-Read Sequencing Services industry.

Chapter 3: Detailed analysis of Long-Read Sequencing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Long-Read Sequencing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Long-Read Sequencing Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Long-Read Sequencing Services Industry Trends Table 2. Long-Read Sequencing Services Industry Drivers Table 3. Long-Read Sequencing Services Industry Opportunities and Challenges Table 4. Long-Read Sequencing Services Industry Restraints Table 5. Global Long-Read Sequencing Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Long-Read Sequencing Services Revenue Share by Company (2021-2026) Table 7. Global Long-Read Sequencing Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Long-Read Sequencing Services Key Company Manufacturing Base & Headquarters Table 9. Global Long-Read Sequencing Services Company, Product Type & Application Table 10. Global Long-Read Sequencing Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Long-Read Sequencing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Nanopore Sequencing Table 15. Significant Companies of Single-molecule Real-time Sequencing Table 16. Significant Companies of Synthetic Long-read Sequencing Table 17. Global Long-Read Sequencing Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Long-Read Sequencing Services Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Long-Read Sequencing Services Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Long-Read Sequencing Services Sales Value Share by Type (2021-2026) Table 21. Global Long-Read Sequencing Services Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Research Institutes Table 23. Significant Companies of Hospitals Table 24. Significant Companies of Pharmaceutical Table 25. Significant Companies of Others Table 26. Global Long-Read Sequencing Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Long-Read Sequencing Services Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Long-Read Sequencing Services Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Long-Read Sequencing Services Sales Value Share by Application (2021-2026) Table 30. Global Long-Read Sequencing Services Sales Value Share by Application (2027-2032) Table 31. Global Long-Read Sequencing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Long-Read Sequencing Services Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Long-Read Sequencing Services Sales Value Share by Region (2021-2026) Table 34. Global Long-Read Sequencing Services Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Long-Read Sequencing Services Sales Value Share by Region (2027-2032) Table 36. Global Long-Read Sequencing Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Long-Read Sequencing Services Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Long-Read Sequencing Services Sales Value Market Share by Country (2021-2026) Table 39. Global Long-Read Sequencing Services Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Long-Read Sequencing Services Sales Value Market Share by Country (2027-2032) Table 41. Oxford Nanopore Company Information Table 42. Oxford Nanopore Business Overview Table 43. Oxford Nanopore Long-Read Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Oxford Nanopore Long-Read Sequencing Services Product Portfolio Table 45. Oxford Nanopore Recent Development Table 46. Agilent Technologies Company Information Table 47. Agilent Technologies Business Overview Table 48. Agilent Technologies Long-Read Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Agilent Technologies Long-Read Sequencing Services Product Portfolio Table 50. Agilent Technologies Recent Development Table 51. Thermo Fisher Scientific Company Information Table 52. Thermo Fisher Scientific Business Overview Table 53. Thermo Fisher Scientific Long-Read Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Thermo Fisher Scientific Long-Read Sequencing Services Product Portfolio Table 55. Thermo Fisher Scientific Recent Development Table 56. QIAGEN Company Information Table 57. QIAGEN Business Overview Table 58. QIAGEN Long-Read Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. QIAGEN Long-Read Sequencing Services Product Portfolio Table 60. QIAGEN Recent Development Table 61. PacBio Company Information Table 62. PacBio Business Overview Table 63. PacBio Long-Read Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. PacBio Long-Read Sequencing Services Product Portfolio Table 65. PacBio Recent Development Table 66. Illumina Company Information Table 67. Illumina Business Overview Table 68. Illumina Long-Read Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Illumina Long-Read Sequencing Services Product Portfolio Table 70. Illumina Recent Development Table 71. Takara Bio Company Information Table 72. Takara Bio Business Overview Table 73. Takara Bio Long-Read Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Takara Bio Long-Read Sequencing Services Product Portfolio Table 75. Takara Bio Recent Development Table 76. 10X Genomics Company Information Table 77. 10X Genomics Business Overview Table 78. 10X Genomics Long-Read Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. 10X Genomics Long-Read Sequencing Services Product Portfolio Table 80. 10X Genomics Recent Development Table 81. Danaher Company Information Table 82. Danaher Business Overview Table 83. Danaher Long-Read Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Danaher Long-Read Sequencing Services Product Portfolio Table 85. Danaher Recent Development Table 86. Azenta US Company Information Table 87. Azenta US Business Overview Table 88. Azenta US Long-Read Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Azenta US Long-Read Sequencing Services Product Portfolio Table 90. Azenta US Recent Development Table 91. Revvity Company Information Table 92. Revvity Business Overview Table 93. Revvity Long-Read Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Revvity Long-Read Sequencing Services Product Portfolio Table 95. Revvity Recent Development Table 96. New England Biolabs Company Information Table 97. New England Biolabs Business Overview Table 98. New England Biolabs Long-Read Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. New England Biolabs Long-Read Sequencing Services Product Portfolio Table 100. New England Biolabs Recent Development Table 101. BaseClear Company Information Table 102. BaseClear Business Overview Table 103. BaseClear Long-Read Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. BaseClear Long-Read Sequencing Services Product Portfolio Table 105. BaseClear Recent Development Table 106. Element Biosciences Company Information Table 107. Element Biosciences Business Overview Table 108. Element Biosciences Long-Read Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Element Biosciences Long-Read Sequencing Services Product Portfolio Table 110. Element Biosciences Recent Development Table 111. CD Genomics Company Information Table 112. CD Genomics Business Overview Table 113. CD Genomics Long-Read Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. CD Genomics Long-Read Sequencing Services Product Portfolio Table 115. CD Genomics Recent Development Table 116. Sage Sciences Company Information Table 117. Sage Sciences Business Overview Table 118. Sage Sciences Long-Read Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Sage Sciences Long-Read Sequencing Services Product Portfolio Table 120. Sage Sciences Recent Development Table 121. EdenRoc Sciences Company Information Table 122. EdenRoc Sciences Business Overview Table 123. EdenRoc Sciences Long-Read Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. EdenRoc Sciences Long-Read Sequencing Services Product Portfolio Table 125. EdenRoc Sciences Recent Development Table 126. Genewiz Company Information Table 127. Genewiz Business Overview Table 128. Genewiz Long-Read Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Genewiz Long-Read Sequencing Services Product Portfolio Table 130. Genewiz Recent Development Table 131. BGI Group Company Information Table 132. BGI Group Business Overview Table 133. BGI Group Long-Read Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. BGI Group Long-Read Sequencing Services Product Portfolio Table 135. BGI Group Recent Development Table 136. Novogene Company Information Table 137. Novogene Business Overview Table 138. Novogene Long-Read Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Novogene Long-Read Sequencing Services Product Portfolio Table 140. Novogene Recent Development Table 141. Grandomics Company Information Table 142. Grandomics Business Overview Table 143. Grandomics Long-Read Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Grandomics Long-Read Sequencing Services Product Portfolio Table 145. Grandomics Recent Development Table 146. Wuhan Beina Technology Company Information Table 147. Wuhan Beina Technology Business Overview Table 148. Wuhan Beina Technology Long-Read Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Wuhan Beina Technology Long-Read Sequencing Services Product Portfolio Table 150. Wuhan Beina Technology Recent Development Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Long-Read Sequencing Services Product Image Figure 2. Global Long-Read Sequencing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-Read Sequencing Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Long-Read Sequencing Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Nanopore Sequencing Image Figure 8. Single-molecule Real-time Sequencing Image Figure 9. Synthetic Long-read Sequencing Image Figure 10. Global Long-Read Sequencing Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Long-Read Sequencing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Long-Read Sequencing Services Sales Value Share by Type (2021-2032) Figure 13. Research Institutes Image Figure 14. Hospitals Image Figure 15. Pharmaceutical Image Figure 16. Others Image Figure 17. Global Long-Read Sequencing Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Long-Read Sequencing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Long-Read Sequencing Services Sales Value Share by Application (2021-2032) Figure 20. Global Long-Read Sequencing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Long-Read Sequencing Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Long-Read Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 23. North America Long-Read Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Long-Read Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Long-Read Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Long-Read Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Long-Read Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Long-Read Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 29. South America Long-Read Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Long-Read Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Long-Read Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Long-Read Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Nanopore Sequencing
  • Single-molecule Real-time Sequencing
  • Synthetic Long-read Sequencing
Applications
  • Research Institutes
  • Hospitals
  • Pharmaceutical
  • Others
Companies covered
  • Oxford Nanopore
  • Agilent Technologies
  • Thermo Fisher Scientific
  • QIAGEN
  • PacBio
  • Illumina
  • Takara Bio
  • 10X Genomics
  • Danaher
  • Azenta US
  • Revvity
  • New England Biolabs
  • BaseClear
  • Element Biosciences
  • CD Genomics
  • Sage Sciences
  • EdenRoc Sciences
  • Genewiz
  • BGI Group
  • Novogene
  • Grandomics
  • Wuhan Beina Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Long-Read Sequencing Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Long-Read Sequencing Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Long-Read Sequencing Services Market Dynamics
  1. 2.1 Long-Read Sequencing Services Industry Trends
  2. 2.2 Long-Read Sequencing Services Industry Drivers
  3. 2.3 Long-Read Sequencing Services Industry Opportunities and Challenges
  4. 2.4 Long-Read Sequencing Services Industry Restraints
3 Long-Read Sequencing Services Market by Company
  1. 3.1 Global Long-Read Sequencing Services Company Revenue Ranking in 2025
  2. 3.2 Global Long-Read Sequencing Services Revenue by Company (2021-2026)
  3. 3.3 Global Long-Read Sequencing Services Company Ranking (2024-2026)
  4. 3.4 Global Long-Read Sequencing Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Long-Read Sequencing Services Company Product Type and Application
  6. 3.6 Global Long-Read Sequencing Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Long-Read Sequencing Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Long-Read Sequencing Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Long-Read Sequencing Services Market by Type
  1. 4.1 Long-Read Sequencing Services Type Introduction
  2. 4.1.1 Nanopore Sequencing
  3. 4.1.2 Single-molecule Real-time Sequencing
  4. 4.1.3 Synthetic Long-read Sequencing
  5. 4.2 Global Long-Read Sequencing Services Sales Value by Type
  6. 4.2.1 Global Long-Read Sequencing Services Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Long-Read Sequencing Services Sales Value by Type (2021-2032)
  8. 4.2.3 Global Long-Read Sequencing Services Sales Value Share by Type (2021-2032)
5 Long-Read Sequencing Services Market by Application
  1. 5.1 Long-Read Sequencing Services Application Introduction
  2. 5.1.1 Research Institutes
  3. 5.1.2 Hospitals
  4. 5.1.3 Pharmaceutical
  5. 5.1.4 Others
  6. 5.2 Global Long-Read Sequencing Services Sales Value by Application
  7. 5.2.1 Global Long-Read Sequencing Services Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Long-Read Sequencing Services Sales Value by Application (2021-2032)
  9. 5.2.3 Global Long-Read Sequencing Services Sales Value Share by Application (2021-2032)
6 Long-Read Sequencing Services Regional Value Analysis
  1. 6.1 Global Long-Read Sequencing Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Long-Read Sequencing Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Long-Read Sequencing Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Long-Read Sequencing Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Long-Read Sequencing Services Sales Value (2021-2032)
  7. 6.3.2 North America Long-Read Sequencing Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Long-Read Sequencing Services Sales Value (2021-2032)
  10. 6.4.2 Europe Long-Read Sequencing Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Long-Read Sequencing Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Long-Read Sequencing Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Long-Read Sequencing Services Sales Value (2021-2032)
  16. 6.6.2 South America Long-Read Sequencing Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Long-Read Sequencing Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Long-Read Sequencing Services Sales Value Share by Country, 2025 VS 2032
7 Long-Read Sequencing Services Country-level Value Analysis
  1. 7.1 Global Long-Read Sequencing Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Long-Read Sequencing Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Long-Read Sequencing Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Long-Read Sequencing Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Long-Read Sequencing Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Long-Read Sequencing Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Long-Read Sequencing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Oxford Nanopore
  2. 8.1.1 Oxford Nanopore Company Information
  3. 8.1.2 Oxford Nanopore Business Overview
  4. 8.1.3 Oxford Nanopore Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Oxford Nanopore Long-Read Sequencing Services Product Portfolio
  6. 8.1.5 Oxford Nanopore Recent Developments
  7. 8.2 Agilent Technologies
  8. 8.2.1 Agilent Technologies Company Information
  9. 8.2.2 Agilent Technologies Business Overview
  10. 8.2.3 Agilent Technologies Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Agilent Technologies Long-Read Sequencing Services Product Portfolio
  12. 8.2.5 Agilent Technologies Recent Developments
  13. 8.3 Thermo Fisher Scientific
  14. 8.3.1 Thermo Fisher Scientific Company Information
  15. 8.3.2 Thermo Fisher Scientific Business Overview
  16. 8.3.3 Thermo Fisher Scientific Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thermo Fisher Scientific Long-Read Sequencing Services Product Portfolio
  18. 8.3.5 Thermo Fisher Scientific Recent Developments
  19. 8.4 QIAGEN
  20. 8.4.1 QIAGEN Company Information
  21. 8.4.2 QIAGEN Business Overview
  22. 8.4.3 QIAGEN Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 QIAGEN Long-Read Sequencing Services Product Portfolio
  24. 8.4.5 QIAGEN Recent Developments
  25. 8.5 PacBio
  26. 8.5.1 PacBio Company Information
  27. 8.5.2 PacBio Business Overview
  28. 8.5.3 PacBio Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PacBio Long-Read Sequencing Services Product Portfolio
  30. 8.5.5 PacBio Recent Developments
  31. 8.6 Illumina
  32. 8.6.1 Illumina Company Information
  33. 8.6.2 Illumina Business Overview
  34. 8.6.3 Illumina Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Illumina Long-Read Sequencing Services Product Portfolio
  36. 8.6.5 Illumina Recent Developments
  37. 8.7 Takara Bio
  38. 8.7.1 Takara Bio Company Information
  39. 8.7.2 Takara Bio Business Overview
  40. 8.7.3 Takara Bio Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Takara Bio Long-Read Sequencing Services Product Portfolio
  42. 8.7.5 Takara Bio Recent Developments
  43. 8.8 10X Genomics
  44. 8.8.1 10X Genomics Company Information
  45. 8.8.2 10X Genomics Business Overview
  46. 8.8.3 10X Genomics Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 10X Genomics Long-Read Sequencing Services Product Portfolio
  48. 8.8.5 10X Genomics Recent Developments
  49. 8.9 Danaher
  50. 8.9.1 Danaher Company Information
  51. 8.9.2 Danaher Business Overview
  52. 8.9.3 Danaher Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Danaher Long-Read Sequencing Services Product Portfolio
  54. 8.9.5 Danaher Recent Developments
  55. 8.10 Azenta US
  56. 8.10.1 Azenta US Company Information
  57. 8.10.2 Azenta US Business Overview
  58. 8.10.3 Azenta US Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Azenta US Long-Read Sequencing Services Product Portfolio
  60. 8.10.5 Azenta US Recent Developments
  61. 8.11 Revvity
  62. 8.11.1 Revvity Company Information
  63. 8.11.2 Revvity Business Overview
  64. 8.11.3 Revvity Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Revvity Long-Read Sequencing Services Product Portfolio
  66. 8.11.5 Revvity Recent Developments
  67. 8.12 New England Biolabs
  68. 8.12.1 New England Biolabs Company Information
  69. 8.12.2 New England Biolabs Business Overview
  70. 8.12.3 New England Biolabs Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 New England Biolabs Long-Read Sequencing Services Product Portfolio
  72. 8.12.5 New England Biolabs Recent Developments
  73. 8.13 BaseClear
  74. 8.13.1 BaseClear Company Information
  75. 8.13.2 BaseClear Business Overview
  76. 8.13.3 BaseClear Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BaseClear Long-Read Sequencing Services Product Portfolio
  78. 8.13.5 BaseClear Recent Developments
  79. 8.14 Element Biosciences
  80. 8.14.1 Element Biosciences Company Information
  81. 8.14.2 Element Biosciences Business Overview
  82. 8.14.3 Element Biosciences Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Element Biosciences Long-Read Sequencing Services Product Portfolio
  84. 8.14.5 Element Biosciences Recent Developments
  85. 8.15 CD Genomics
  86. 8.15.1 CD Genomics Company Information
  87. 8.15.2 CD Genomics Business Overview
  88. 8.15.3 CD Genomics Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CD Genomics Long-Read Sequencing Services Product Portfolio
  90. 8.15.5 CD Genomics Recent Developments
  91. 8.16 Sage Sciences
  92. 8.16.1 Sage Sciences Company Information
  93. 8.16.2 Sage Sciences Business Overview
  94. 8.16.3 Sage Sciences Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sage Sciences Long-Read Sequencing Services Product Portfolio
  96. 8.16.5 Sage Sciences Recent Developments
  97. 8.17 EdenRoc Sciences
  98. 8.17.1 EdenRoc Sciences Company Information
  99. 8.17.2 EdenRoc Sciences Business Overview
  100. 8.17.3 EdenRoc Sciences Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 EdenRoc Sciences Long-Read Sequencing Services Product Portfolio
  102. 8.17.5 EdenRoc Sciences Recent Developments
  103. 8.18 Genewiz
  104. 8.18.1 Genewiz Company Information
  105. 8.18.2 Genewiz Business Overview
  106. 8.18.3 Genewiz Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Genewiz Long-Read Sequencing Services Product Portfolio
  108. 8.18.5 Genewiz Recent Developments
  109. 8.19 BGI Group
  110. 8.19.1 BGI Group Company Information
  111. 8.19.2 BGI Group Business Overview
  112. 8.19.3 BGI Group Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 BGI Group Long-Read Sequencing Services Product Portfolio
  114. 8.19.5 BGI Group Recent Developments
  115. 8.20 Novogene
  116. 8.20.1 Novogene Company Information
  117. 8.20.2 Novogene Business Overview
  118. 8.20.3 Novogene Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Novogene Long-Read Sequencing Services Product Portfolio
  120. 8.20.5 Novogene Recent Developments
  121. 8.21 Grandomics
  122. 8.21.1 Grandomics Company Information
  123. 8.21.2 Grandomics Business Overview
  124. 8.21.3 Grandomics Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Grandomics Long-Read Sequencing Services Product Portfolio
  126. 8.21.5 Grandomics Recent Developments
  127. 8.22 Wuhan Beina Technology
  128. 8.22.1 Wuhan Beina Technology Company Information
  129. 8.22.2 Wuhan Beina Technology Business Overview
  130. 8.22.3 Wuhan Beina Technology Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Wuhan Beina Technology Long-Read Sequencing Services Product Portfolio
  132. 8.22.5 Wuhan Beina Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst